Standard Biotools (LAB) EBT Growth (1y) (2011 - 2026)
Standard Biotools (LAB) EBT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 186.78 Bn | 179.48 Bn | 6.27 Bn | -18.50% |
| 2 | Stryker | 131.95 Bn | 129.07 Bn | 3.81 Bn | 11.26% |
| 3 | Medtronic | 111.27 Bn | 102.05 Bn | 6.41 Bn | 45.44% |
| 4 | Boston Scientific | 68.58 Bn | 67.13 Bn | 3.61 Bn | 44.35% |
| 5 | Edwards Lifesciences | 48.31 Bn | 44.63 Bn | 1.29 Bn | 5.78% |
| 6 | GE HealthCare Technologies | 29.23 Bn | 26.94 Bn | 1.98 Bn | -27.02% |
| 7 | Dexcom | 28.90 Bn | 27.78 Bn | 750.30 Mn | 74.66% |
| 8 | Smith & Nephew | 28.19 Bn | 27.62 Bn | - | - |
| 9 | Koninklijke Philips | 24.33 Bn | 21.29 Bn | 2.01 Bn | 82.69% |
| 10 | Standard Biotools | 305.20 Mn | -149.97 Mn | 11.31 Mn | 37.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.78% |
| Dec 31, 2025 | -84.36% |
| Sep 30, 2025 | -50.91% |
| Jun 30, 2025 | 28.04% |
| Mar 31, 2025 | 26.66% |
| Dec 31, 2024 | 186.91% |
| Sep 30, 2024 | -4.08% |
| Jun 30, 2024 | -51.77% |
| Mar 31, 2024 | -93.18% |
| Dec 31, 2023 | -91.07% |
| Sep 30, 2023 | 30.50% |
| Jun 30, 2023 | 74.31% |
| Mar 31, 2023 | 78.43% |
| Sep 30, 2022 | 43.58% |
| Jun 30, 2022 | -70.77% |
| Mar 31, 2022 | -275.08% |
| Sep 30, 2021 | -755.77% |
| Jun 30, 2021 | -169.44% |
| Mar 31, 2021 | -23.00% |
| Dec 31, 2020 | -38.18% |